Abstract
In general, a disease manifests not from malfunction of individual molecules but from failure of the relevant system or network, which can be considered as a set of interactions or edges among molecules. Thus, instead of individual molecules, networks or edges are stable forms to reliably characterize complex diseases. This paper reviews both traditional node biomarkers and edge biomarkers, which have been newly proposed. These biomarkers are classified in terms of their contained information. In particular, we show that edge and network biomarkers provide novel ways of stably and reliably diagnosing the disease state of a sample. First, we categorize the biomarkers based on the information used in the learning and prediction steps. We then briefly introduce conventional node biomarkers, or molecular biomarkers without network information, and their computational approaches. The main focus of this paper is edge and network biomarkers, which exploit network information to improve the accuracy of diagnosis and prognosis. Moreover, by extracting both network and dynamic information from the data, we can develop dynamical network and edge biomarkers. These biomarkers not only diagnose the immediate pre-disease state but also detect the critical molecules or networks by which the biological system progresses from the healthy to the disease state. The identified critical molecules can be used as drug targets, and the critical state indicates the critical point of disease control. The paper also discusses representative biomarker-based methods.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol, 2012, 29: 613–624
Hood L, Friend SH. Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol, 2011, 8: 184–187
Auffray C, Charron D, Hood L. Predictive, preventive, personalized and participatory medicine: back to the future. Genome Med, 2010, 2: 57
Zeng T, Sun SY, Wang Y, Zhu H, Chen L. Network biomarkers reveal dysfunctional gene regulations during disease progression. FEBS J, 2013, doi:10.1111/febs.12536
Zhong Q, Simonis N, Li QR, Charloteaux B, Heuze F, Klitgord N, Tam S, Yu H, Venkatesan K, Mou D, Swearingen V, Yildirim MA, Yan H, Dricot A, Szeto D, Lin C, Hao T, Fan C, Milstein S, Dupuy D, Brasseur R, Hill DE, Cusick ME, Vidal M. Edgetic perturbation models of human inherited disorders. Mol Syst Biol, 2009, 5: 321
Zhang W, Zeng T, Chen L. EdgeMarker: identifying differentially correlated molecule pairs as edge-biomarkers. J Theor Biol, 2014, doi:10.1016/j.jtbi.2014.05.041
Chen L, Liu R, Liu ZP, Li M, Aihara K. Detecting early-warning signals for sudden deterioration of complex diseases by dynamical network biomarkers. Sci Rep, 2012, 2: 342
Liu R, Li M, Liu ZP, Wu J, Chen L, Aihara K. Identifying critical transitions and their leading biomolecular networks in complex diseases. Sci Rep, 2012, 2: 813
Liu R, Wang X, Aihara K, Chen L. Early diagnosis of complex diseases by molecular biomarkers, network biomarkers, and dynamical network biomarkers. Med Res Rev, 2013, doi:10.1002/med.21293
Liu R, Yu X, Liu X, Xu D, Aihara K, Chen L. Identifying critical transitions of complex diseases based on a single sample. Bioinformatics, 2014, doi:10.1093/bioinformatics/btu084
Li M, Zeng T, Liu R, Chen L. Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform, 2013, doi: 10.1093/bib/bbt1027
Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet, 2001, 10: 705–713
Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, Grallert H, Xu T, Bader E, Huth C, Mittelstrass K, Döring A, Meisinger C, Gieger C, Prehn C, Roemisch-Margl W, Carstensen M, Xie L, Yamanaka-Okumura H, Xing G, Ceglarek U, Thiery J, Giani G, Lickert H, Lin X, Li Y, Boeing H, Joost HG, de Angelis MH, Rathmann W, Suhre K, Prokisch H, Peters A, Meitinger T, Roden M, Wichmann HE, Pischon T, Adamski J, Illig T. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol, 2012, 8: 615
Wemmie JA, Taugher RJ, Kreple CJ. Acid-sensing ion channels in pain and disease. Nat Rev Neurosci, 2013, 14: 461–471
Lampertico P, Vigano M, Cheroni C, Facchetti F, Invernizzi F, Valveri V, Soffredini R, Abrignani S, de Francesco R, Colombo M. IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B. Hepatology, 2013, 57: 890–896
Joshita S, Umemura T, Katsuyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Komatsu M, Ichijo T, Matsumoto A, Yoshizawa K, Kamijo N, Ota M, Tanaka E. Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection. Hum Immunol, 2012, 73: 298–300
Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton HC, Pochanard P, Mozes E, Garraway LA, Pe’er D. An integrated approach to uncover drivers of cancer. Cell, 2010, 143: 1005–1017
Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet, 2010, 11: 31–46
Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature, 2009, 461: 218–223
Ren X, Wang Y, Chen L, Zhang XS, Jin Q. ellipsoidFN: a tool for identifying a heterogeneous set of cancer biomarkers based on gene expressions. Nucleic Acids Res, 2013, 41: e53
Pritchard JK. Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet, 2001, 69: 124–137
Jorde LB. Linkage disequilibrium and the search for complex disease genes. Genome Res, 2000, 10: 1435–1444
Stower H. Complex disease: family history versus SNPs for disease predictions. Nat Rev Genet, 2012, 13: 827
van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature, 2002, 415: 530–536
Li J, Lenferink AE, Deng Y, Collins C, Cui Q, Purisima EO, O’Connor-McCourt MD, Wang E. Identification of high-quality cancer prognostic markers and metastasis network modules. Nat Commun, 2010, 1: 34
Gormley M, Dampier W, Ertel A, Karacali B, Tozeren A. Prediction potential of candidate biomarker sets identified and validated on gene expression data from multiple datasets. BMC Bioinformatics, 2007, 8: 415
Koiol JA, Feng AC, Jia Z, Wang Y, Goodison S, McClelland M, Mercola D. The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis. Bioinformatics, 2009, 25: 54–60
Holec M, Klema J, Zelezny F, Tolar J. Comparative evaluation of set-level techniques in predictive classification of gene expression samples. BMC Bioinformatics, 2012, 13(Suppl 10): S15
Lee S, Kim J. A comparative study on gene-set analysis methods for assessing differential expression associated with the survival phenotype. BMC Bioinformatics, 2011, 12: 377
Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics, 2010, 11: 277
Levine DM, Haynor DR, Castle JC, Stepaniants SB, Pellegrini M, Mao M, Johnson JM. Pathway and gene-set activation measurement from mRNA expression data: the tissue distribution of human pathways. Genome Biol, 2006, 7: R93
Lee E, Chuang HY, Kim JW, Ideker T, Lee D. Inferring pathway activity toward precise disease classification. PLoS Comput Biol, 2008, 4: e1000217
Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet, 2011, 12: 56–68
Kreeger PK, Lauffenburger DA. Cancer systems biology: a network modeling perspective. Carcinogenesis, 2010, 31: 2–8
Drier Y, Sheffer M, Domany E. Pathway-based personalized analysis of cancer. Proc Natl Acad Sci USA, 2013, 110: 6388–6393
Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol, 2007, 3: 140
Dao P, Wang K, Collins C, Ester M, Lapuk A, Sahinalp SC. Optimally discriminative subnetwork markers predict response to chemotherapy. Bioinformatics, 2011, 27: i205–213
He D, Liu ZP, Chen L. Identification of dysfunctional modules and disease genes in congenital heart disease by a network-based approach. BMC Genomics, 2011, 12: 592
Eddy JA, Hood L, Price ND, Geman D. Identifying tightly regulated and variably expressed networks by Differential Rank Conservation (DIRAC). PLoS Comput Biol, 2010, 6: e1000792
Jin G, Zhou X, Cui K, Zhang XS, Chen L, Wong ST. Cross-platform method for identifying candidate network biomarkers for prostate cancer. IET Syst Biol, 2009, 3: 505–512
Winter C, Kristiansen G, Kersting S, Roy J, Aust D, Knosel T, Rummele P, Jahnke B, Hentrich V, Ruckert F, Niedergethmann M, Weichert W, Bahra M, Schlitt HJ, Settmacher U, Friess H, Büchler M, Saeger HD, Schroeder M, Pilarsky C, Grützmann R. Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol, 2012, 8: e1002511
Jiao Y, Lawler K, Patel GS, Purushotham A, Jones AF, Grigoriadis A, Tutt A, Ng T, Teschendorff AE. DART: denoising algorithm based on relevance network topology improves molecular pathway activity inference. BMC Bioinformatics, 2011, 12: 403
Wen Z, Liu ZP, Liu Z, Zhang Y, Chen L. An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer. J Am Med Inform Assoc, 2013, 20: 659–667
Hofree M, Shen JP, Carter H, Gross A, Ideker T. Network-based stratification of tumor mutations. Nat Methods, 2013, 10: 1108–1115
Dutkowski J, Ideker T. Protein networks as logic functions in development and cancer. PLoS Comput Biol, 2011, 7: e1002180
Liu X, Liu ZP, Zhao XM, Chen L. Identifying disease genes and module biomarkers by differential interactions. J Am Med Inform Assoc, 2012, 19: 241–248
Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol, 2009, 27: 199–204
Wang YC, Chen BS. A network-based biomarker approach for molecular investigation and diagnosis of lung cancer. BMC Med Genomics, 2011, 4: 2
Qian L, Zheng H, Zhou H, Qin R, Li J. classification of time series gene expression in clinical studies via integration of biological network. PLoS One, 2013, 8: e58383
Yu X, Li G, Chen L. Prediction and early diagnosis of complex diseases by edge-network. Bioinformatics, 2013, doi: 10.1093/bioin-formatics/btt620
van de Leemput IA, Wichers M, Cramer AO, Borsboom D, Tuerlinckx F, Kuppens P, van Nes EH, Viechtbauer W, Giltay EJ, Aggen SH, Derom C, Jacobs N, Kendler KS, van der Maas HL, Neale MC, Peeters F, Thiery E, Zachar P, Scheffer M. Critical slowing down as early warning for the onset and termination of depression. Proc Natl Acad Sci USA, 2014, 111: 87–92
Ichikawa S, Ito Y, Uchida K. Periodic Lyapunov differential equation for noise evaluation in oscillatory genetic networks. IEEE Control Applications (CCA) & Intelligent Control (ISIC), 2009. 83–88
Sejdic E. Medicine: adapt current tools for handling big data. Nature, 2014, 507: 306
Restifo NP. A “big data” view of the tumor “immunome”. Immunity, 2013, 39: 631–632
Gijzen H. Development: big data for a sustainable future. Nature, 2013, 502: 38
Boyle J. Biology must develop its own big-data systems. Nature, 2013, 499: 7
Marx V. Biology: the big challenges of big data. Nature, 2013, 498: 255–260
Buxton B, Hayward V, Pearson I, Karkkainen L, Greiner H, Dyson E, Ito J, Chung A, Kelly K, Schillace S. Big data: the next Google. Interview by Duncan Graham-Rowe. Nature, 2008, 455: 8–9
Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol, 2012, 8: 565
Liu M, Liberzon A, Kong SW, Lai WR, Park PJ, Kohane IS, Kasif S. Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet, 2007, 3: e96
Ulitsky I, Krishnamurthy A, Karp RM, Shamir R. DEGAS: de novo discovery of dysregulated pathways in human diseases. PLoS One, 2010, 5: e13367
Zhang B, Li H, Riggins RB, Zhan M, Xuan J, Zhang Z, Hoffman EP, Clarke R, Wang Y. Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics, 2009, 25: 526–532
Zhang B, Tian Y, Jin L, Li H, Shih Ie M, Madhavan S, Clarke R, Hoffman EP, Xuan J, Hilakivi-Clarke L, Wang Y. DDN: a caBIG(R) analytical tool for differential network analysis. Bioinformatics, 2011, 27: 1036–1038
Kim Y, Kim TK, Yoo J, You S, Lee I, Carlson G, Hood L, Choi S, Hwang D. Principal network analysis: identification of subnetworks representing major dynamics using gene expression data. Bioinformatics, 2011, 27: 391–398
West J, Bianconi G, Severini S, Teschendorff AE. Differential network entropy reveals cancer system hallmarks. Sci Rep, 2012, 2: 802
Sun SY, Liu ZP, Zeng T, Wang Y, Chen L. Spatio-temporal analysis of type 2 diabetes mellitus based on differential expression networks. Sci Rep, 2013, 3: 2268
Zeng T, Zhang CC, Zhang W, Liu R, Liu J, Chen L. Deciphering early development of complex diseases by progressive module network. Methods, 2014, http://dx.doi.org/10.1016/j.ymeth.2014.01.021
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Zeng, T., Zhang, W., Yu, X. et al. Edge biomarkers for classification and prediction of phenotypes. Sci. China Life Sci. 57, 1103–1114 (2014). https://doi.org/10.1007/s11427-014-4757-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-014-4757-4